| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
12,494 |
11,321 |
$693K |
| 67028 |
Intravitreal injection of a pharmacologic agent |
11,764 |
9,713 |
$474K |
| 92134 |
|
17,215 |
15,454 |
$298K |
| J9035 |
Injection, bevacizumab, 10 mg |
3,222 |
2,737 |
$180K |
| J0178 |
Injection, aflibercept, 1 mg |
187 |
165 |
$162K |
| J2777 |
Injection, faricimab-svoa, 0.1 mg |
115 |
95 |
$111K |
| 92202 |
|
6,538 |
6,033 |
$49K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
736 |
680 |
$49K |
| 92235 |
|
764 |
709 |
$32K |
| 92014 |
Ophthalmological services: medical examination and evaluation, comprehensive, established patient |
2,038 |
1,793 |
$16K |
| 92226 |
|
2,353 |
1,777 |
$16K |
| 92250 |
|
473 |
429 |
$7K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
92 |
88 |
$5K |
| J3590 |
Unclassified biologics |
1,434 |
1,103 |
$2K |
| 92225 |
|
170 |
135 |
$217.06 |
| G9903 |
Patient screened for tobacco use and identified as a tobacco non-user |
3,165 |
2,860 |
$0.00 |
| G8397 |
Dilated macular or fundus exam performed, including documentation of the presence or absence of macular edema and level of severity of retinopathy |
418 |
362 |
$0.00 |
| 67228 |
|
15 |
14 |
$0.00 |
| G8427 |
Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications |
4,809 |
4,315 |
$0.00 |
| 2022F |
|
928 |
839 |
$0.00 |
| 5010F |
|
419 |
364 |
$0.00 |
| G2102 |
Dilated retinal eye exam with interpretation by an ophthalmologist or optometrist documented and reviewed |
61 |
59 |
$0.00 |